Publicaciones (34) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. "HIDE and SEEK" NEUROSENSORY RETINAL DETACHMENTS in PERIPAPILLARY PACHYCHOROID SYNDROME ASSOCIATED with PULMONARY ARTERIAL HYPERTENSION

    Retinal Cases and Brief Reports, Vol. 16, Núm. 1, pp. 118-125

  2. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues

    Drug metabolism and disposition: the biological fate of chemicals, Vol. 50, Núm. 12, pp. 1483-1492

  3. Adaptive Optics Imaging to Analyze the Photoreceptor Layer Reconstitution in Acute Syphilitic Posterior Placoid Chorioretinopathy

    Life, Vol. 12, Núm. 9

  4. Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  5. Applications of Non-Coding RNAs in Patients With Retinoblastoma

    Frontiers in Genetics, Vol. 13

  6. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  7. Clinical characteristics of full thickness macular holes that closed without surgery

    British Journal of Ophthalmology, Vol. 106, Núm. 10, pp. 1463-1468

  8. Clinical evaluation of meibomian gland dysfunction in patients with keratoconus

    Contact Lens and Anterior Eye, Vol. 45, Núm. 3

  9. Corneal power measurements by ray tracing in eyes after small incision lenticule extraction for myopia with a combined Scheimpflug Camera–Placido disk topographer

    International Ophthalmology, Vol. 42, Núm. 3, pp. 921-931

  10. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

  11. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    The Lancet, Vol. 399, Núm. 10326, pp. 729-740

  12. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    The Lancet, Vol. 399, Núm. 10326, pp. 741-755

  13. Eficiencia al digitalizar un archivo fotográfico antiguo de oftalmología

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 9, pp. 510-513

  14. El anhelo de los congresos presenciales

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 2, pp. 61-62

  15. Eye symptoms in acromegaly, beyond visual field alteration

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 4, pp. 309-311

  16. Fully-Automatic 3D Intuitive Visualization of Age-Related Macular Degeneration Fluid Accumulations in OCT Cubes

    Journal of Digital Imaging, Vol. 35, Núm. 5, pp. 1271-1282

  17. GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma

    Cancers, Vol. 14, Núm. 13

  18. Identificación de extensión extraocular en el melanoma uveal mediante ecografía oftalmológica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 2, pp. 70-76

  19. Immunomodulatory Effect of Human Lactoferrin on Toll-like Receptors 2 Expression as Therapeutic Approach for Keratoconus

    International journal of molecular sciences, Vol. 23, Núm. 20

  20. Improvement of Retinal Images Affected by Cataracts

    Photonics, Vol. 9, Núm. 4